07:00 , Jul 11, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Malaria Endothelial protein C receptor (EPCR) In vitro and cell culture studies suggest disrupting the interaction...
07:00 , Apr 23, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease ...
07:00 , Apr 23, 2009 |  BC Innovations  |  Targets & Mechanisms

New fronts against malaria

A key challenge in combating malaria is the rapid development of resistance that Plasmodium falciparum parasites mount against older drugs.Now, a pair of articles describes two new ways to attack the infection: inhibiting host calpain...
08:00 , Mar 28, 2005 |  BioCentury  |  Product Development

Tilting at windmills

Third World Solutions Tilting at windmills The experience of Maxygen Inc. in monetizing the various applications of its directed evolution platform perfectly illustrates the problems companies encounter when they try to commercialize vaccines, even with the best...
08:00 , Mar 25, 2002 |  BC Week In Review  |  Company News

National Institute of Allergy and Infectious Diseases other research news

Researchers published in the Proceedings of the National Academy of Sciences evidence that y179 could be used as a malaria vaccine. In 6 monkeys vaccinated with y179 plus complete Freund's adjuvant (FA), 0 monkeys developed...